Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Neoadjuvant chemotherapy confers greater survival in breast cancer patients
October 27th, 2005
Neoadjuvant chemotherapy can effectively confer a greater survival advantage in breast cancer patients. "Neoadjuvant chemotherapy has become the standard treatment for stage III breast cancer. Gratifying results in these patients prompted this prospective, nonrandomized study of neoadjuvant chemotherapy in stage II breast cancer," scientists in the United States reported. "This study presents our experience with neoadjuvant chemotherapy in 127 patients with stage II carcinoma of the breast. Patients with stages IIA (T>3.0 cm) and IIB carcinoma were considered for this study and underwent treatment with cyclic chemotherapy until a plateau of...
Source: Women's Health Weekly (2005-10-27)
|
